Director, Acute Stroke Service, Massachusetts General Hospital; Associate Professor of Neurology, Harvard Medical School

Neurology

Natalia S. Rost, MD works in the field of Neurology. She graduated from Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine Natalia S. Rost, MD is a published MD. She published 70 publications, including: 'Integrative Mouse and Human Studies Implicate ANGPT1 and ZBTB7C as Susceptibility Genes to Ischemic Injury.' Natalia Rost accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Endovascular Stroke Treatment Outcomes After Patient Selection Based on Magnetic Resonance Imaging and Clinical Criteria.
• Integrative Mouse and Human Studies Implicate ANGPT1 and ZBTB7C as Susceptibility Genes to Ischemic Injury.
• Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic Stroke onset.
• B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis.
• Metabolic determinants of white matter hyperintensity burden in patients with ischemic Stroke.
• Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic Stroke.
• Safeguards to Prevent Neurologic Complications after Epidural Steroid Injections: Consensus Opinions from a Multidisciplinary Working Group and National Organizations.
• Recommendations from the international Stroke genetics consortium, part 1: standardized phenotypic data collection.
• Agreement between TOAST and CCS ischemic Stroke classification: The NINDS SiGN Study.
• Determinants of Early Outcomes in Patients with Acute Ischemic Stroke and Proximal Artery Occlusion.
• The TeleStroke mimic (TM)-score: a prediction rule for identifying Stroke mimics evaluated in a TeleStroke Network.
• Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in ...
• Meta-analysis of Genome-wide Association Studies Identifies 1q22 as a Susceptibility Locus for IntraCerebral Hemorrhage.
• Severity of leukoaraiosis, leptomeningeal collaterals, and clinical outcomes after intra-arterial therapy in patients with acute ischemic Stroke.
• Socioeconomic status does not predict cocaine use among ischemic Stroke patients: A nested case-control study.
• White Matter Hyperintensity Volume Correlates with Matrix Metalloproteinase-2 in Acute Ischemic Stroke.
• Improving Door-to-Needle Times: A Single Center Validation of the Target Stroke Hypothesis.
• Predicting Hematoma Expansion After Primary IntraCerebral Hemorrhage.
• Clinical neurogenetics: Stroke.
• Characteristics and Outcomes Among Patients Transferred to a Regional Comprehensive Stroke Center for Tertiary Care.
• Predictors of Hematoma Volume in Deep and Lobar Supratentorial IntraCerebral Hemorrhage.
• Warfarin and Statins are Associated with Hematoma Volume in Primary Infratentorial IntraCerebral Hemorrhage.
• Burden of blood pressure-related alleles is associated with larger hematoma volume and worse outcome in intraCerebral hemorrhage.
• Common Variants Within Oxidative Phosphorylation Genes Influence Risk of Ischemic Stroke and IntraCerebral Hemorrhage.
• Assessing variability in neurointerventional practice patterns for acute ischemic Stroke.
• Severity of leukoaraiosis in large vessel atherosclerotic Disease.
• Elderly Patients Are at Higher Risk for Poor Outcomes After Intra-Arterial Therapy.
• Implementation of a patient selection protocol for intra-arterial therapy increases treatment rates in patients with acute ischemic Stroke.
• Apolipoprotein E Genotype Predicts Hematoma Expansion in Lobar IntraCerebral Hemorrhage.
• Predictors of Increased Intravenous Tissue Plasminogen Activator Use Among Hospitals Participating in the Massachusetts Primary Stroke Service Program.
• Prestroke Dementia is Associated with Poor Outcomes after Reperfusion Therapy among Elderly Stroke Patients.
• Variability in the Use of Intravenous Thrombolysis for Mild Stroke: Experience Across the SPOTRIAS Network.
• Brain Natriuretic Peptide Predicts Functional Outcome in Ischemic Stroke.
• Body Mass Index and Etiology of IntraCerebral Hemorrhage.
• Statin treatment and functional outcome after ischemic Stroke: case-control and meta-analysis.
• The effect of survival bias on case-control genetic association studies of highly lethal Diseases.
• Packed Red Blood Cell Transfusion and Decreased Mortality in IntraCerebral Hemorrhage.
• Prognosis in intraCerebral hemorrhage.
• White matter hyperintensity burden and susceptibility to Cerebral ischemia.
• Principal-component analysis for assessment of population stratification in mitochondrial medical genetics.
• Chromosome 9p21 in ischemic Stroke: population structure and meta-analysis.
• Posterior circulation Stroke after C1-C2 intraarticular facet steroid injection: evidence for diffuse microvascular injury.
• Determinants of white matter hyperintensity volume in patients with acute ischemic Stroke.
• Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic Stroke.
• Anemia and hematoma volume in acute intraCerebral hemorrhage.
• Risk of thromboembolism following acute intraCerebral hemorrhage.
• Prediction of functional outcome in patients with primary intraCerebral hemorrhage: the FUNC score.
• Effect of statins on intraCerebral hemorrhage outcome and recurrence.
• The genetic architecture of intraCerebral hemorrhage.
• The recognition and treatment of rabies: a case report and discussion.
• Reducing Door-to-Puncture Times for Intra-Arterial Stroke Therapy: A Pilot Quality Improvement Project.
• Diffusion weighted imaging reversibility in the Brainstem following successful recanalization of acute basilar artery occlusion.
• Variants at APOE influence risk of deep and lobar intraCerebral hemorrhage.
• APOE genotype and extent of bleeding and outcome in lobar intraCerebral haemorrhage: a genetic association study.
• Common mitochondrial sequence variants in ischemic Stroke.
• Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic Stroke.
• Remote supervision of IV-tPA for acute ischemic Stroke by telemedicine or telephone before transfer to a regional Stroke center is feasible and safe.
• Severity of leukoaraiosis correlates with clinical outcome after ischemic Stroke.
• Silent ischemic infarcts are associated with hemorrhage burden in Cerebral amyloid angiopathy.
• Prior antiplatelet therapy and outcome following intraCerebral hemorrhage: a systematic review.
• Aspirin and recurrent intraCerebral hemorrhage in Cerebral amyloid angiopathy.
• Many hypotheses but no replication for the association between PDE4D and Stroke.
• Plasma concentration of C-reactive protein and risk of ischemic Stroke and transient ischemic attack: the Framingham study.
• Immunochemical analyses of estrogen receptors in human breast tumors by a novel monoclonal estrogen receptor antibody (EVG F9).
• Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group.
• Severity of leukoaraiosis determines clinical phenotype after Brain infarction.
• Statin use and outcome after intraCerebral hemorrhage: case-control study and meta-analysis.
• White matter hyperintensity volume is increased in small vessel Stroke subtypes.
• Warfarin-related intraventricular Hemorrhage: imaging and outcome.

Schools

---

• Boston University School Of Medicine

• Massachusetts General Hospital

• Partners Neurology Boston

Procedures Preformed

---

• EEG (Electroencephalogram)

Conditions Treated

---

• Alzheimer's Disease
• Ataxia
• Brain Aneurysm
• Carotid Artery Disease
• View All

Doctors Specialties

---

• Vascular Neurology
• Neurology

Accepted Insurances

---

Education

---

• Massachusetts General Hospital
• Boston University School of Medicine

Hospital

---

• Massachusetts General Hospital

Drug Facts

---

NPI NUMBER		1144211640
NPPES Provider LastName		ROST
NPPES Provider FirstName		NATALIA
NPPES Provider ZIPCode		021142621
NPPES Provider State		MA
Specialty Description		Neurology
Total Claim Count		20.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1144211640
Last Name Of The Provider	ROST
First Name Of The Provider	NATALIA
View All

Similar Doctors

---

	Dr. Leigh R. Hochberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Ashutosh P. Jadhav, MD This Doctor is OpenDoctor Recommended.
	Dr. Eric E. Smith, MD
	Dr. Wendy K. Liew, MD
	Dr. Sherry H. Chou, MD This Doctor is OpenDoctor Recommended.
	Dr. Norberto Alvarez, MD This Doctor is OpenDoctor Recommended.
	Dr. Hiroyuki Nodera, MD This Doctor is OpenDoctor Recommended.
	Dr. Raul G. Nogueira, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Maitreyi Mazumdar, MD This Doctor is OpenDoctor Recommended.
	Dr. Aleksandra Pikula, MD This Doctor is OpenDoctor Recommended.
	Dr. Vaijayantee K. Belle, MD
	Dr. Hesham E. Masoud, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog